The deal sets the biosimilar’s potential US launch date to no later than April 2...
However, the adenosine receptor antagonist is still being developed for the trea...
There are many period products on the market from pads, tampons and cups to disc...
Nektar Therapeutics filed a lawsuit accusing Eli Lilly of undermining a drug dev...
Sage Therapeutics said Monday that it may need to reduce costs, including throug...
"As far as actual violence goes, statistically, health care is four or five time...
The FDA approved a rapid-acting oral drug made by Sage Therapeutics to treat pos...
When a patient signs on for medical care, they’re agreeing to lose money, time, ...
"Having that kind of expertise on what it really means to walk in that person's ...
“We need to have some kind of reserve of machines that can be quickly accessed a...
“People infected with [tuberculosis] … need good living conditions, nutrition, a...
An already record-setting summer heat wave will continue through August and will...
The FDA on Friday approved Zurzuvae, a rapid-acting medicine from Sage Therapeut...
The organization that runs ProMed, an early warning system on disease outbreaks,...
A new study emphasizes how, because of disruptions in care during the pandemic, ...
Mark Del Monte, CEO of the American Academy of Pediatrics, called the restrictio...
